NDC 80587-184 - Chlo Tuss
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80587-184
- Package NDCs from labels
- 80587-184-01, 80587-184-02
- Manufacturer
- Prime Labs LLC dba Quality CDMO
- Effective date
- 2025-11-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Chlo Tuss - Prime Labs LLC dba Quality CDMO | Prime Labs LLC dba Quality CDMO | 2025-11-20 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOLOGEN | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | Kramer Novis | 656ea9ba-c9cf-44c6-af40-b8ba292ce38a | 2025-12-05 | Warnings | BPA9UT29BS |
| G-DOLOGEN | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | Kramer Novis | 7a4e1d64-2510-405f-a1dc-e02a803b6fbd | 2025-12-05 | Warnings | BPA9UT29BS |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 2968PHW8QP |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 2968PHW8QP |
| Aleve-D Sinus and Headache | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | Bayer HealthCare LLC. | 5ab980c0-c48a-233b-e053-2991aa0a4fd1 | 2025-12-04 | Warnings | 6V9V2RYJ8N |
| Aleve-D Sinus and Cold | NAPROXEN SODIUM, PSEUDEOEPHEDRINE HYDROCHLORIDE | Bayer HealthCare LLC. | 599ea6c8-03ad-536e-e053-2991aa0a83a3 | 2025-12-04 | Warnings | 6V9V2RYJ8N |
| Capmist DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Capital Pharmaceutical, LLC | 63733ac3-859e-4a8e-8717-d852bd303408 | 2025-12-03 | Warnings | 6V9V2RYJ8N |
| ALA-HIST IR | DEXBROMPHENIRAMINE MALEATE | Poly Pharmaceuticals, Inc. | 0d203b5c-8b10-428b-8703-17be6b4ce6eb | 2025-12-03 | Warnings | BPA9UT29BS |
| Alahist PE | DEXBROMPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | Poly Pharmaceuticals, Inc. | ada2d582-5813-2029-e053-2a95a90ae567 | 2025-12-03 | Warnings | BPA9UT29BS |
| BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASK | BUTYLENE GLYCOL, GLYCERIN, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT | BUDDATE Co Ltd | 464988ad-557e-13f5-e054-00144ff8d46c | 2025-11-30 | Warnings | PDC6A3C0OX |
| BUDDATE LOTUS MOISTURE ESSENCE | GLYCERIN, NIACINAMIDE, NELUMBO NUCIFERA FLOWER EXTRACT, PORTULACA OLERACEA EXTRACT | BUDDATE Co Ltd | 46499995-8b13-3e5c-e054-00144ff88e88 | 2025-11-30 | Warnings | PDC6A3C0OX |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | ab19b011-0a51-4f04-9881-d9fc7cae95ae | 2025-11-25 | 1Q73Q2JULR | |
| Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE | Chartwell Governmental & Specialty RX, LLC | a19b75d4-67de-4904-8487-1f9b3368c833 | 2025-11-25 | Warnings, Adverse reactions | 6V9V2RYJ8N |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.